Patellar tendon: From tendinopathy to rupture by Rosso, Federica et al.
Available online at www.sciencedirect.comScienceDirect
Asia-Pacific Journal of Sports Medicine, Arthroscopy, Rehabilitation and Technology 2 (2015) 99e107
www.ap-smart.comReview article
Patellar tendon: From tendinopathy to rupture
Federica Rosso a,*, Davide Edoardo Bonasia b, Umberto Cottino c, Federico Dettoni a,
Matteo Bruzzone a, Roberto Rossi a,b
a Department of Orthopaedics and Traumatology, Azienda Ospedaliera Mauriziano Umberto I, Largo Turati 62, 10128, Torino, Italy
b Department of Orthopaedics and Traumatology, Azienda Ospedaliera Citta della Salute e della Scienza, Centro Traumatologico Ortopedico Hospital,
Via Zuretti, Torino, Italy
c Department of Orthopedics and Traumatology, University of Study of Torino, Via Po 8, Torino, Italy
Received 29 January 2015; revised 7 April 2015; accepted 3 July 2015
Available online 7 August 2015AbstractPatellar tendinopathy is very common in patients complaining of anterior knee pain. Its aetiology is still unclear, but neovascularisation
seems to play a role. Different treatments have been proposed overtime, from rehabilitation to platelet-rich-plasma injections, but there is no
agreement on the best treatment protocol. The final stage of patellar tendinopathy is patellar tendon rupture. In these cases surgical treatment is
often required. The aim of this literature review is to focus on the aetiology, diagnosis, and treatment of both patellar tendinopathy and rupture.
We report the conservative treatments proposed for patellar tendinopathy and the surgical techniques described for its rupture.
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The most common complaint of patients with patellar
tendinopathy is pain around the patella. Different authors have
demonstrated that the disease has a degenerative aetiology
rather than an inflammatory aetiology.1
Blazina was the first to define this pathology as “Jumper's
knee”, and to divide it into four different stages: (1) pain after
sport activity; (2) pain during sport activity without perfor-
mance limitation; (3) pain during or after sport activity with
performance limitation; and (4) patellar rupture.2 The last
stage will be further defined in the next section.
Patellar tendinopathy can be further divided into acute:
onset in < 2 weeks; subacute: between 2 weeks and 6 weeks;
and chronic: > 6 weeks.3 Repetitive micro trauma was* Corresponding author. Azienda Ospedaliera Mauriziano Umberto I,
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ndemonstrated to be the major cause of patellar tendinopathy;
for this reason it is also defined as “overuse pathology”. It is
more frequent in volleyball, basketball, and soccer players,
because of changes of direction, jumping, and running
activities.4
Patellar tendinopathy is disabling, most of all for athletes.
About 30% of athletes affected by patellar tendinopathy do not
return to sport for 6 months, with 50% of these having anterior
knee pain 15 years after diagnosis.5
Different authors have proposed that an excessive me-
chanical loading placed on the tendon as the mechanism for
the development of patellar tendinopathy. Recently Zhang
et al6 tried to investigate tendon mechanic-biological re-
sponses through an in vivo (mouse treadmill running model)
and an in vitro model. In the in vivo study they found that
treadmill running elevated the expression of mechanical
growth factors and enhanced the proliferative potential of
tendon stem cells (TSC). Besides, moderate treadmill running
upregulated different tenocyte-related genes (i.e., collagen
type I), but did not affect nontenocyte-related genes. On thee Society. Published by Elsevier (Singapore) Pte Ltd. This is an open access
c-nd/4.0/).
Figure 1. Magnetic resonance imaging caption showing insertional patellar
tendinopathy (red circle).
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upregulation of both tenocyte and nontenocyte related genes.
In the in vitro part of the study they demonstrated that low
mechanical stretching of TSCs from both patellar and Achilles
tendon increased the expression of only tenocyte-related
genes. However, high mechanical stretching increased both
the expression of tenocyte and nontenocyte related genes. The
authors concluded that excessive mechanical loading may
cause anabolic changes in the tendons, inducing the differen-
tiation of TSC into nontenocytes, which may lead to degen-
erative tendinopathy development.
Ferretti et al7 evaluated 18 patellar tendon fragments from
surgeries and observed that the histological alterations were
localised in the tendon-bone junctions, while the tendon itself
was healthy.
From a histological point of view there is a “disorganisa-
tion” in the collagen fibres associated with fibrosis, increased
cellularity, and vascularity. Inflammation is poor in a chronic
setting, while it plays a fundamental role in the first phase of
the pathology.8 Because of the continuous stress on the tendon,
the tenocytes produce more cytokines and interleukins,
causing some micro fractures in the collagen fibres.8
The tendon alterations include an increase in collagen type
III fibres and the deposition of glycosaminoglycans. There is a
different kind of regulation of the homeostasis of the matrix
enzymes, which are involved in collagen, metalloproteinase,
and their inhibitor degradation. Macroscopically the healthy
tendon is not a neural structure; during the process, however,
the innervations increase, with chronic pain due to cytokines,
pain mediators, hypoxia, and pH changes.9
Neovascularisation seems to be involved in pain generation,
but this is still a debated issue. There are different studies on
shoulder rotator cuff, but diminished vascularisation seems to
be a more credible theory. However there is no certain aeti-
ology of the pain in this pathology.10
Recently some genetic studies tried to better understand the
aetiology of this pathology by analysing the DNA sequences
which can be involved in tendon alterations. Some poly-
morphisms have been recently described for the collagen V
gene,11 as well as some genetic variations on type II metal-
loproteinase tissue inhibitor and some other genes (i.e.,
ADAMTS14). Those genes seemed to be involved in increasing
or decreasing Achilles tendinopathy.12
Diagnosis of patellar tendinopathy
Patients with patellar tendinopathy usually describe
anterior knee pain, which is exacerbated by activity or
sometimes by prolonged knee flexion. The onset of pain is
often insidious, sometimes related to a period of increased
activity, and most of all referred to the inferior pole of the
patella. In severe cases patients can experience pain also
during daily activities. In the evaluation of tendon overuse,
different scales were proposed, but they often fail to
discriminate symptomatic differences.2 Recently, a more
accurate scale was developed: the Victorian Institute Sports
tendon Assessment (VISA) score. This scale was studiedspecifically to assess symptoms and functionality in patellar
tendinopathy, with good inter and intra-observer reliability
and stability.13 Physical findings are fairly straightforward in
patellar tendinopathy; the most consistent factor is localised
tenderness at the inferior pole of the patella, but with low
sensitivity and specifity.14 The most important differential
diagnoses with patellar tendinopathy are patello-femoral pain
syndrome and Hoffa impingement. Plain X-rays are useful to
assess patella position, associated pathologies (i.e., Osgood-
Schlatter), or intratendinous calcifications.15 Ultra-
sonoghraphic (US) evaluation is typically the second line
imaging, showing the typical echogenicity of the fibrillar
structure of the patellar tendon.16 In patellar tendinitis there
is degradation and disorganisation of collagen fibres that is
depicted as a well-defined hypoechogenic zone often asso-
ciated with tendon thickening.17 In advanced cases small foci
of hyper reflectivity (i.e., calcifications) or intratendinous
clefts can be found. In association with US, colour and
Power Doppler can be useful to assess intratendinous vas-
cularisation.18 Magnetic resonance imaging (MRI) can also
be useful to assess areas of increased signal intensity, espe-
cially on short echo time images. The detection of partial
tears is difficult, but it is better evaluated on T2-weighted
images with high signal intensity.19 Figure 1 shows an
MRI image of patellar tendinopathy (in the red circle).
Treatment options and results of patellar tendinopathy
The lack of basic knowledge on the aetiology and pain
mechanisms associated with patellar tendinopathy is reflected
in the existence of many different treatment protocols.15 The
aim of this section is to analyse the different possible treat-
ments described in recent literature.
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in patellar tendinopathy therapy. The exercises can be per-
formed with single leg squat at 25 of inclination or with
weight-bearing squat using leg press. These exercises seem to
promote the collagen fibres' cross-linkage and tendinous
reshaping, and so tendinopathy prevention. In the literature,
decreased pain and neovascularisation in patellar tendinopathy
treated with this rehabilitation protocol were demonstrated
with good long-term results.5Extracorporeal shock wave therapyExtracorporeal shock wave therapy (ESWT) is a procedure
that has good results on chronic tendinopathy and a positive
effect on pain and functionality. Different studies demon-
strated good results with an overall improvement from 73.5%
to 87.5% on patients' functionality.20 A recent systematic re-
view evaluated the effect of ESWT on athletes affected by
patellar tendinopathy without interrupting their sport activity.
The authors included seven studies, but only two of them had
good quality methodology. They concluded good clinical
outcomes in athletes treated with ESWT, with an improvement
in about 74.7% of patients.21
Zwerver et al22 performed the VISA questionnaire at 1
week, 12 weeks, and 22 weeks after ESWT treatment and they
concluded that, despite the athletes continued training and
competitions, no worsening of the symptoms could be detec-
ted. The same authors in a randomised study in 201123 re-
ported their results using ESWT in 62 athletes, concluding that
after 22 weeks no differences in outcomes could be detected
compared with the control group (placebo). However, this
poor result can be explained by the short time for functional
recovery the patients had during the competitive season.23
Patellar tendinopathy has been described also in patients
who underwent anterior cruciate ligament reconstruction using
bone-tendon-bone graft. In this population Wang et al20 and
Peers et al24 in two different studies described good results
using ESWT, with good patients' satisfaction, improved tendon
vascularization, and reduced tendon thickness at the US
compared with the control group.
Despite the demonstrated utility of ESWT in a chronic
setting, there is a limited evidence to recommend a specific
treatment protocol for in-season athletes in an acute setting.21
However, in literature there is great nonuniformity on treat-
ment methodology with ESWT. ESWT can be divided into
localised and radial based on the physical characteristics of
the wave. Most of the studies reporting on ESWT used
focalised waves, and the results on patellar tendinopathy are
unclear.25
In conclusion, a definitive answer on the efficacy of ESWT
therapy is difficult. Based on the literature, an ESWT treat-
ment using low frequencies and low energy waves, without
anaesthesia, after an initial period of rest, seems to be
reasonable. However there is a lack of evidence regarding the
type of waves to use (focalised or radial) and their efficacy.25Percutaneous techniqueThere are different percutaneous and injective therapies
described in literature to treat patellar tendinopathy: platelet-
rich-plasma (PRP), autologous blood, needling, corticoste-
roid injections, and sclerosant therapy. Recently some authors
demonstrated the inefficacy of topical nitroglycerin in asso-
ciation with eccentric exercises,26 and for this reason we will
not focus on this treatment.PRPPRP is an autologous preparation of platelets in a small
volume of plasma. In the a cells of platelets there are different
growth factors [transforming growth factor-b1, transforming
growth factor-b2, platelet-derived growth factor (PDGF)-AA,
PDGF-BB, PDGF-AB, growth factor-1, epidermal growth
factor, hepatocyte growth factor], that work together to
improve wound healing, to reduce inflammatory response, and
to improve regeneration of damaged tissues.
Using PRP to improve tendon healing has been recently
proposed. Volpi et al27 in 2007 reported their results on eight
patients treated with a single PRP injection in association with
a rehabilitation protocol to treat chronic tendinopathy. One
hundred and twenty days after the injection the patients re-
ported a significant improvement in pain, with associated
improvement in MRI imaging in 80% of patients.27
Kon et al28 in 2009 described their results on 20 patients
treated with three PRP injections (1 every 15 days containing
about 6.8 million platelets) at a minimum follow-up of 6
months. The authors concluded that there was a significant
improvement in all the scores, but there was no control group.
Filardo et al29 performed a similar study comparing patients
treated with PRP injections (3 injections, 1 every 15 days) with
those treated with physical therapy only. No differences were
detected between the two groups in pain scores, satisfaction, or
recovery time, but the activity level significantly improved in
the PRP-group. De Vos et al30 published a randomised control
trial (RCT) on 54 patients affected by Achilles tendinopathy
and randomly allocated into a PRP treatment group or placebo
group. The mean VISA-A score significantly improved in both
the groups, without any statistically significant differences. The
authors concluded that in patients with chronic Achilles ten-
dinopathy treated with eccentric exercises, a PRP injection
compared with a saline injection did not result in greater
improvement in pain and activity.
van Ark et al31 in a systematic review analysed three
studies with good clinical outcomes using PRP, concluding
that all the studies had some bias and limitations. Recently
Gonsens et al32 reported their results on 36 patients, under-
lying that one single PRP injection had positive results on pain
and functionality, most of all on patients who had not under-
gone any previous percutaneous treatment. Vetrano et al33
compared patients treated with PRP injections or ESWT in a
RCT. In the first group, two US-guided autologous PRP in-
jections every 2 weeks were performed while the second group
of patients underwent three ESWT sessions every 48e72
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underwent a standardised rehabilitation protocol for 2 weeks
after the last injections-physical therapy session. The authors
concluded on a significant improvement in both groups at 2
months, 6 months, and 12 months of follow-up, with better
results at the last follow-up in the PRP group.
Lane et al,34 in a rabbit model, demonstrated increased
cellular activity at 7 days in the PRP-group, confirming that
PRP factors are “short-acting”. Other authors confirmed that
tumour necrosis factor-a and vascular endothelial growth
factor levels returned to basal levels 24 hours after the
injection.35
Recently Charousset et al36 reported on 28 athletes (17
professional, 11 semiprofessional) with chronic patellar ten-
dinopathy refractory to nonoperative management and treated
with three US-guided pure PRP injections into the site of the
tendinopathy. After 2 years of follow-up the authors concluded
that three consecutive US-guided PRP injections significantly
improved symptoms and function in this population, with MRI
3 months after the last injection showing normal tendon
architecture.
In conclusion there are still different debates in the literature
regarding PRP injections in patellar tendinopathy treatment,
mainly due to the variability of the treatment protocol reported.
Recently a systematic review was published in the Cochrane
database, underling the limitations of the published studies and
concluding that there is low evidence on the efficacy of PRP
injection in patellar tendinopathy treatment.37 In 2014 Andia
et al38 published a systematic review on PRP treatment of
painful tendinopathy, including 13 prospective controlled
studies. The authors concluded that PRP treatment can achieve
better intermediate to long-term pain control compared with
control interventions, but further studies circumventing het-
erogeneity are needed to reach firm conclusions.
Wang39 recently published a review in which he described
the different factors potentially influencing the conflicting
outcomes of PRP, dividing them into PRP-related and patient-
related factors. The PRP-related factors may include: (1)
preparation (i.e., containing white blood cells); (2) platelet
concentration; (3) activated or nonactivated PRP; (4) method
of PRP activation (i.e., calcium or thrombin); (5) mode of
application (injection or implantation); and (6) frequency of
PRP application. The patient-associated factors include: (1)
age; (2) timing of tendon injury; (3) type of tissue injured (i.e.,
tendon, soft tissue); (4) patient activity level; (5) treatment
history; and (6) postrecovery rehabilitation.Autologous blood and needlingThe aim of these techniques is to increase bleeding in the
pathologic tendon and to induce granulation tissue formation
and subsequent healing.
James et al40 compared the results of needling alone,
autologous blood alone, and an association of both techniques,
with the latter technique obtaining the best clinical outcomes.Their study had some limitations, including the absence of a
control group.Sclerosing injectionsTendinous vascularisation seems to play a role in pain
pathogenesis; for this reason using some substances limiting
neovascularisation can be a therapeutic option.
In a recent RCT, Willberg et al41 compared the results
obtained with sclerosing injection or arthroscopic shaving.
The authors concluded that good outcomes are obtained with
both treatments, but in the group with arthroscopic shaving,
pain reduction and patient satisfaction were greater. Hoksrud
et al42 evaluated the efficacy of sclerosing injections
obtaining some improvement in pain and knee function, but
most of the patients still complained about knee pain at 2
years follow-up.Corticosteroid injectionsThe anti-inflammatory properties of corticosteroid in-
jections are well known; however there is some concern about
using them in tendinopathy because of some collateral effects,
like tendon rupture.
There are three clinical trials in the literature describing
the results of corticosteroid injections in patellar tendinop-
athy. All the studies described a short-term improvement in
pain, but with some cases of atrophy and tendon rupture, and
poor long-term outcomes.43e45 Finally, Zhang et al46
demonstrated that one single corticosteroid injection stimu-
lated tendinous cell differentiation into cartilage or adipose
tissue, reducing the number of cells and increasing the risk of
tendon rupture.Surgical treatmentAfter 6 months of ineffective conservative treatment in
Blazina stage III disease, a surgical indication may be neces-
sary. In this chapter we will review only surgical treatment
without tendon rupture; surgical treatment of tendon rupture
will be described later.
The aims of surgical treatment are: removing fibrous ad-
herences, re-establishing vascularisation, and trying to
improve the biological stimulus for healing. If the pathology is
localised in the centre of the tendon, there is some agreement
in the efficacy of longitudinal tenotomies and degenerated
tissue removal.47
In cases of insertional tendinopathy there is no agreement
in the literature on the best surgical treatment. Arthroscopic
treatment allows the patients a quicker recovery with a low
complication rate. In these cases, treatment options are
shaving,41,48 peritenonion release in association with osseous
denervation,49 and inferior patellar pole resection.50
It is still debated if the association between arthroscopic
shaving and bone procedures is correct. To date there is no
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best surgical treatment choice for insertional tendinopathy.51
Patellar tendon rupture
Extensor apparatus injuries have an incidence rate of
0.5e6%, but they are serious injuries because the extensor
mechanism is essential for normal human gait, and can lead to
great disability.52
Patellar tendon ruptures are more likely caused by direct or
indirect trauma in young people; however they can be the
extreme consequence of patellar tendinopathy, micro traumas,
or overuse pathology.53
There are few data regarding patellar tendon ruptures in
active people, because they are more frequent after total knee
arthroplasty. However, in the literature there are a lot of case
reports with small numbers with the focus being placed on
different repairing techniques despite the aetiology or diag-
nostic process used.
Typically these lesions occur in active young people
(younger than 40 years) and they are usually caused by an in-
direct trauma to the knee, like a sudden contraction of the
quadriceps with the knee in slight flexion (sudden impulsion,
sprint, avoiding a fall, etc.).54 Some authors also reported on
traumatic patellar tendon lesions due to rapid dynamic loading
conditions occurring in many sports situations; however, in-
juries in maximum tensile stress during static test conditions are
less common.55
Strain forces on the patellar tendon are greater at the osteo-
tendinous insertion than in the mid-substance: for this reason
mid-substance lesions are much rarer than avulsions in normal
tendons. Because of the great forces needed to break a healthy
tendon, there is some agreement in the literature about the
involvement of a degenerated tendon in patellar tendon rup-
tures, most of all in cases of a mid-substance lesion.56
Different authors have described the possible predisposing
conditions for patellar tendon rupture, such as: corticosteroids
local injections57; diabetes58; micro trauma2; rheumatic dis-
eases59; metabolic disorders60; iatrogenic lesions (anterior
cruciate ligament reconstruction)61; and fluoroquinolone sys-
temic use.62Diagnosis of patellar tendon ruptureTo correctly evaluate patients affected by patellar tendon
rupture, a good patient history is the first step. Typically the
patients describe unexpected pain and subsequent knee
impotence that can be sometimes associated to a fall, during a
fast movement. A history of previous patellar tendinopathy
should be assessed, and the surgeon should ask for other
comorbidities or potential risk factors, as mentioned above. At
clinical inspection the knee is usually swollen and, frequently,
the patella cannot be recognised because of the oedema.
Palpating the knee, a defect in the patellar tendon and a patella
alta can be identified, especially in complete ruptures. Intra-
articular haematoma is usually considerable and should be
evacuated in emergency. The active knee extension may beimpossible, both in some partial tendon rupture it is conserved.
However in cases of complete tendon rupture the surgeon
should search for extension lag sign.
A plain X-ray evaluation, both in antero-posterior and
lateral views, is the first line imaging. A patellar avulsion, a
patella alta, or a tibial tuberosity fracture can be suggestive of
extensor mechanism rupture. In an emergency, a US can be
useful to assess complete patellar tendon ruptures. The main
advantage of this technique is the possibility to perform a
dynamic evaluation; on the contrary its main limitation is poor
reproducibility.
The gold standard for tendon ruptures is an MRI, but it is
considered to bemore expensive and less available.63 Computed
tomography scan can be useful in cases of suspected tendon
avulsion, but it is not useful in mid-substance lesions.Treatment options and outcomes of patellar tendon
rupture
Acute setting
Incomplete ruptures with intact function may be treated
nonoperatively with 2e3 weeks of full extension
immobilisation.64
In cases of incomplete lesions with functional deficits or
complete ruptures, surgical treatment is required. In the acute
setting the repair should be performed as soon as possible in
order to have the best chance to achieve a tension-free su-
ture.54 In the treatment of acute patellar tendon repair, isolated
suture repair is not recommended because of the high failure
rate. Besides, most of the lesions occur in the osteo-tendinous
junctions, facilitating a trans-osseous suture.65
Normally the anterior approach through a midline incision
is the best choice; then the surgeon should perform an accurate
dissection of the retinacular tears and the tendon ends should
be debrided. The inferior pole of the patella is accurately
decorticated to improve bleeding and, consequently, healing.
A pair of continuous, locking heavy (No. 2 or 5), nonab-
sorbable sutures are placed in the tendon using a Krakow or
similar suture technique. Three parallel bone tunnels are
drilled with a 2.5 mm drill from distal to proximal in the
patella, a suture passer is used to pass the free suture ends in
the bone tunnels, with the central one containing two sutures.
Once the correct patellar position and tracking are checked
the strands are tensioned with the knee fully extended to
approximate the tendon to the inferior pole of the patella. The
retinacula are now closed with an absorbable suture and the
knee is flexed at 90 to test the repair.64 Some authors
described using suture anchors to repair patellar tendon rup-
tures, concluding that it can result in a low-profile construct
and better recreation of tendon insertion into the inferior pole
of the patella.66 Other authors reported on a lower gap for-
mation after cyclic loading in suture anchors compared with
the transpatellar technique.67,68
In rare cases of mid-substance ruptures, continuous locking
stitches can be used and patellar bone tunnels can be per-
formed to hold the proximal fragment.69 Alternatively a neu-
tralisation nonabsorbable wire or heavy sutures can be placed
Figure 2. (A) Patellar tendon rupture to the proximal insertion. (B) Final results of chronic patellar tendon rupture reconstruction using hamstring.
Table 1
Description of studies reporting on acute or chronic patellar tendon ruptures outcomes.
Study No. Median
F-UP
Technique Results
Siwek & Rao75 31 patients
(25 acute/6 chronic)
2e11 y Acute: Bunnell pull-out wire augmented
with a Steinman
Chronic: initially treated with traction
Acute repair: 20 excellent results, 4 good, & 1
rerupture
Chronic repair: 2 excellent results, 3 good, & 1
unsatisfactory result
Dejour et al82 13 (chronic) 8.6 mo Contra lateral bone-patellar-bone tendon Correction of the extensor lags in all the cases &
mean postoperative flexion of 91
Hsu et al69 35 patients
(all acute)
Not reported Primary repair with a neutralisation wire 57% of outcomes excellent; 28.6% good; & 14.2%
unsatisfactory. No rerupture of the tendon
Marder &
Timmerman74
14 patients (acute) 2.6 y Primary repair with Krackow & patella
tunnels
86% excellent results with patients resuming their
previous activity level
Kasten et al71 32 patients 8.1 (1e18) y End-to-end suture augmented with wire
cerclage or PDS
2 of 22 patients had an extension lag in Group A
(wire cerclage) compared with no extension lag in
Group B (PDS cerclage). The average Hospital for
Special Surgery Knee Score was 92 (SD 17) in
Group A & 96 (SD 12) in Group B. 3 patients were
dissatisfied
Bhargava et al86 11 patients (acute) 26 (14e38) mo Suture repair of the patella tendon &
retinacula protection with a cerclage
wire
No patients had fixed flexion deformities or
demonstrated an extensor lag & the average range of
motion was 0e137. Mean loss of power of 6%
(range, 2e11%) when measuring concentric
extension & a mean loss of 7% power in concentric
flexion
Ramseier et al65 19 57 mo Suture repair associated with
McLaughlin cerclage
No difference between the range of motion &
muscle strength when the injured leg was compared
to the noninjured leg
Bushnell et al67 14 29 mo Suture anchors No intraoperative complication, 3 failures (21%),
mean extension gap 1
West et al87 30 4 (1e12) y Trans-patellar repair with nonabsorbable
wire augmentation
No complication. No evidence of shortening or
lengthening of the tendon. At 6 months, 40 had full
extension, & 10 lacked 3e10 of active extension
(not specified if quadriceps or patellar tendon)
Massoud88 12 45 (24e48) mo Tran patellar suture reinforced with a
“suture line tension-regulating suture”
The active knee movement averaged 0e154.6
compared with 0e156.7 in the contra lateral knee
Wiegand et al83 16 28 (16e36) mo Y-shaped flap folded back from the
vastus lateralis fascia
The mean Knee Society pain & function scores as
well as the average range of motion of the knee
increased significantly after the operations
Maffulli et al76 19 5.8 (4e7.8) y Ipsilateral hamstring tendon graft
reconstruction
The mean modified Cincinnati & Kujala scores were
notably improved. All patients had returned to
ordinary daily activities. 14 patients were very
satisfied, 3 were satisfied, 1 was moderately
satisfied, & 1 was unsatisfied
Jain et al79 9 4.5 y Percutaneos semintendinosus
reconstruction
At Lysholm score & Siwek & Rao grading were
good to excellent in all patients, & at 12 months, all
patients showed quadriceps strength  80% of
opposite quadriceps
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tunnel in the proximal tibia; this technique has been used to
provide additional stability to the primary repair.70
Some authors have suggested different surgical techniques
to augment a primary repair if it is too tenuous, using tension
wire anchored to the patella or strenuous PDS augmentation.71
However the most commonly described augmentation is the
one performed using semitendinosus autograft. In this tech-
nique, a tibial tunnel is normally drilled from medial to lateral
to the anterior tibial tuberosity and the tendon is passed
through it. A second tunnel is than drilled in the patella and the
tendon is passed through it from lateral to medial. At this point
the end of the tendon is sutured back to its tibial insertion with
nonabsorbable stitches.72,73 However, it is not clear if an
augmentation is really needed in acute patellar tendon repair.74
Chronic setting
In a chronic setting, primary repair is difficult because of
tendon retraction, tendon quality, and adhesion formation.64
Despite some authors describing primary repair using fascia
lata or hamstring augmentation, sometimes the reconstruction
is the only suitable option.75 In chronic patellar tendon
rupture, hamstrings can be used to perform a reconstruction
similar to the one described for augmentation. The tendons are
normally left inserted, the tibial tunnel is then drilled, and the
tendons are passed all around the patella in a circular or figure-
of-eight fashion and then sutured back to their insertion.76e78
Different variations of the original technique were described,
as a percutaneous one or a technique in which the hamstrings
were passed through a longitudinal bone tunnel and fixed to
the superior pole of the patella with an Endobutton (Smith &
Nephew, London, UK).79,80 However, in cases of chronic
rupture, the augmentation is always suggested, even in cases in
which a primary repair is possible. Figure 2 shows the results
of a patellar tendon reconstruction using hamstrings.
Some authors have described the use of a contra-lateral
central third of patellar tendon with proximal and distal
bone plugs in cases of chronic patellar tendon rupture.81,82
Good clinical outcomes were also reported using a Y-shaped
flap folded back from the vastus lateralis fascia.83
Recently different authors suggested using allograft tissue,
commonly Achilles tendon, in patellar tendon reconstruction.
The bone plugs of the allograft are normally fixed to the tibial
tubercle after a squared trench is performed. The tendon is
split into three parts: the central one is passed through a lon-
gitudinal patellar tunnel and sutured to the superior pole of the
patella and the other two parts are sutured to the lateral and
medial retinaculum with nonabsorbable stitches.84 Also syn-
thetic grafts were proposed in low-demand patients because of
the low biological profile of synthetic grafts.85
Table 1 shows a literature review of outcomes in the surgical
treatment of both acute and chronic patellar tendon rupture.
Conclusion
Chronic patellar tendinopathy is frequent, most of all in
athletes. The physiopathology of tendinopathy is still unclear,despite the amount of studies published, as well as the role of
different inflammatory pathways. There is no standardised
treatment protocol in patellar tendinopathy, with few high-
level studies. Rehabilitation plays a fundamental role in
patellar tendinopathy treatment, but other different techniques,
such as PRP injection, were recently proposed.
For patellar tendon rupture, both in an acute setting and
chronic setting, treatment indications are clearer.
In an acute setting, a direct repair using transpatellar bone
tunnels is the gold standard treatment, and it can be associated
with an augmentation. In a chronic setting, patellar tendon
reconstruction is often the best choice. However the best graft
choice or surgical technique is still unclear.
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